AI in Medical Imaging: The Road from Idea to Impact

Have you ever wondered what it takes to develop commercial AI software in radiology, from conception to the clinic? In this session, we ask industry experts to provide insight into the application development lifecycle, from initial market analysis, business strategy, new technology R&D, FDA regulation, and clinical deployment. Importantly, what are the major factors that influence the final products available to radiologists today, and what does the future hold? In addition, we invite each vendor to discuss areas of exciting innovation, from cutting-edge machine learning methods to creative, unique, and impactful clinical applications.

Objectives

Identify key factors that guide development of AI algorithms in radiology

Discuss the current limitations in realizing the full potential of commercial AI software

Forecast key future trends and highlight areas of active investment among major AI vendors in medical imaging

Speakers

peter chang-cropped
Dawn Cram
Headshot of Ankur Sharma
eliot_siegel_400x400 1

Peter D. Chang, MD
Associate Professor, Radiological Sciences and Computer Science, University of California, Irvine
Director, UCI Center for AI in Diagnostic Medicine

Dawn Cram, CIIP
Product Manager
PaxeraHealth

Ankur Sharma, MD
Head of Medical Affairs Medical Devices & Digital Radiology
Bayer

Eliot Siegel, MD, FSIIM
Professor of Radiology, University of Maryland School of Medicine
Chief, Imaging Services, VA Maryland Health Care System

CMIMI24 V2 800 X 542

Date

Mon, Oct 21

Location

GSU Metcalf Hall Small

Time

5:30 – 6:30 PM ET

Continuing Education

ASRT-RT | CAMPEP-MPCEC | SIIM IIP-CIIP